Cibus Global LLC Total Assets
Cibus Global LLC total assets. Based on the latest financial reports, Cibus Global LLC (CBUS) holds total assets worth $313.45 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Cibus Global LLC market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Cibus Global LLC (2015–2025)
Total assets of Cibus Global LLC from 2015 to 2025. This chart illustrates how Cibus Global LLC's total assets have evolved over time, based on quarterly financial data. See latest Cibus Global LLC stock price today for real-time trading data and today's change.
Cibus Global LLC - Asset Composition Analysis
Cibus Global LLC Total Assets Breakdown (December 2025)
Cibus Global LLC total assets breakdown as of December 2025. Cibus Global LLC's total assets of $313.45 Million consist of 4.0% current assets and 96.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.3% |
| Accounts Receivable | $703.00K | 0.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $31.68 Million | 10.4% |
| Goodwill | $232.52 Million | 76.2% |
Asset Composition Trend (2015–2025)
This chart illustrates how Cibus Global LLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Cibus Global LLC to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cibus Global LLC's current assets represent 4.0% of total assets in 2025, a decrease from 96.3% in 2015.
- Cash Position: Cash and equivalents constituted 3.3% of total assets in 2025, down from 95.0% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 86.0% of total assets, an increase from 0.0% in 2015.
- Asset Diversification: The largest asset category is goodwill at 76.2% of total assets.
Cibus Global LLC Competitors by Total Assets
Key competitors of Cibus Global LLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
USA | $1.26 Billion |
|
Verona Pharma plc
F:I9SA
|
Germany | €572.87 Million |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
|
USA | $641.76 Million |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.46 Billion |
|
Metsera, Inc. Common Stock
NASDAQ:MTSR
|
USA | $639.66 Million |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
Bavarian Nordic
CO:BAVA
|
Denmark | Dkr14.95 Billion |
|
Hebei Changshan Biochem Pharma
SHE:300255
|
China | CN¥4.66 Billion |
Cibus Global LLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.62 | 1.78 | 3.35 |
| Quick Ratio | 1.62 | 1.78 | 3.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $9.01 Million | $17.42 Million | $12.11 Million |
Cibus Global LLC - Advanced Valuation Insights
This section examines the relationship between Cibus Global LLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.36 |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | -12.9% |
| Total Assets | $305.05 Million |
| Market Capitalization | $94.77 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cibus Global LLC's assets below their book value (0.31x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Cibus Global LLC's assets decreased by 12.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Cibus Global LLC (2015–2025)
The table below shows the annual total assets of Cibus Global LLC from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $305.05 Million | -12.86% |
| 2024-12-31 | $350.07 Million | -35.70% |
| 2023-12-31 | $544.41 Million | +2328.13% |
| 2022-12-31 | $22.42 Million | -39.72% |
| 2021-12-31 | $37.19 Million | -41.27% |
| 2020-12-31 | $63.33 Million | -28.12% |
| 2019-12-31 | $88.10 Million | -25.84% |
| 2018-12-31 | $118.79 Million | +64.61% |
| 2017-12-31 | $72.17 Million | +334.14% |
| 2016-12-31 | $16.62 Million | -36.05% |
| 2015-12-31 | $26.00 Million | -- |
About Cibus Global LLC
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-th… Read more